Details : Includes cancers of the colon and rectum. 

Research Evidence : GcMAF (Gc protein-derived macrophage-activating factor) is a type of immunotherapy that has been explored for its potential in cancer treatment. Here are 14 possible reasons how GcMAF could help in the treatment of colorectal cancer : 

1. Immune System Activation : GcMAF activates macrophages, which are crucial for attacking cancer cells.
2. Inhibition of Tumor Growth : GcMaf helps inhibit the growth of tumors by enhancing the body’s natural immune response.
3. Reduction of Nagalase Levels : Cancer cells produce an enzyme called nagalase that suppresses the immune system. GcMAF can counteract this effect.
4. Improved Survival Rates : Studies suggest that GcMAF can improve survival rates in cancer patients.
5. Enhanced Effectiveness of Other Treatments : GcMAF  works synergistically with other treatments like surgery, chemotherapy, and radiation.
6. Reduction of Cancer Recurrence : By boosting the immune system, GcMAF can help reduce the likelihood of cancer recurrence.
7. Minimal Side Effects : Compared to traditional cancer treatments, GcMAF has fewer side effects and no known long term side effects.
8. Support for Overall Health : GcMAF can improve overall immune function, which is beneficial for cancer patients.
9. Targeted Action : It specifically targets cancer cells without harming healthy cells.
10. Potential for Use in Various Cancers :  GcMAF has shown potential in treating different types of cancer.
11. Natural Protein : As a naturally occurring protein in the body, GcMAF is considered a more natural treatment option.
12. Reduction of Inflammation : GcMAF helps reduce inflammation, which is often associated with cancer.
13. Improved Quality of Life : Patients experience an improved quality of life due to the immune-boosting effects of GcMAF.
14. Potential for Long-Term Remission : Some case studies suggest that GcMAF can lead to long-term remission in cancer patients.